Curaleaf shares down 8% after FDA sends warning letter over CBD health claims
Cannabis Law Report
JULY 24, 2019
Food and Drug Administration sent a warning letter to the company for selling CBD-based products that claim to treat serious diseases. Based on our review of your website, your “CBD Lotion,” “CBD Pain-Relief Patch,” “CBD Tincture,” and “CBD Disposable Vape Pen” products are drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C.
Let's personalize your content